Decision: RFU v Ashley Johnson
A Decision in the case of Rugby Football Union (RFU) v Ashley Johnson has been published by the National Anti-Doping Panel (NADP).
On 07 February 2018, Mr Johnson was subject to an Out-of-Competition test, the analysis of which produced an Adverse Analytical Finding for the presence of hydrochlorothiazide. Hydrochlorothiazide is defined in Section S5 (Diuretics and Masking Agents) of the World Anti-Doping Agency Prohibited List and is a Specified Substance.
Mr Johnson was subsequently charged with committing an Anti-Doping Rule Violation (ADRV) for the Presence of a Prohibited Substance under World Rugby Regulation 21.2.1, with the matter being referred to the NADP for determination.
An NADP Tribunal consisting of Mr William Norris QC (Chairman), Sir Richard McLaughlin and Prof. Dorian Haskard held a hearing on 12 July to determine the case. The Tribunal concluded the ADRV had been established, that Mr Johnson had acted without Significant Fault or Negligence and that the applicable sanction to be applied was six months, to run from 07 February 2018 (the date of testing).
The full NADP Decision can be accessed via the related links tab on the right-hand side.
The National Anti-Doping Panel (NADP) is the United Kingdom’s independent tribunal responsible for adjudicating anti-doping disputes in sport. It is operated by Sport Resolutions and is entirely independent of both UKAD and the RFU, who are responsible for investigating, charging and prosecuting cases before the NADP.